Follitropin

This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on October 27, 2022.

Return to the list of Patented Medicine Litigation page.





Follitropin

GONAL – F, PERGOVERIS, PUREGON FOR INJECTION 150 I.U., PUREGON FOR INJECTION 75 I.U. – EMD SERONO A DIVISION OF EMD INC CANADA (NOC Search)

Patents:

  • 2335340:

Unknown/Other


Return to the Patented Medicine Litigation page.

Canadian Intellectual Property